Current medical practice and the Food and Drug Administration. Some evidence for the existing gap.
D000328:Adult; D000368:Aged; D000493:Allopurinol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000787:Angina Pectoris / Q000188:drug therapy; D002506:Cephalexin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D003078:Colchicine / Q000008:administration & dosage; D004232:Diuretics / Q000008:administration & dosage; D004348:Drug Labeling; D011307:Drug Prescriptions; D004358:Drug Therapy; D006073:Gout / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007501:Iron / Q000008:administration & dosage; D008875:Middle Aged; D010820:Physicians; D011183:Postoperative Complications / Q000517:prevention & control; D011433:Propranolol / Q000008:administration & dosage / Q000627:therapeutic use; D012189:Retrospective Studies; D014481:United States; D014486:United States Food and Drug Administration; D014527:Uric Acid / Q000097:blood
D004232:Diuretics; D014527:Uric Acid; D000493:Allopurinol; D011433:Propranolol; D007501:Iron; D002506:Cephalexin; D003078:Colchicine